Portfolio company
Lumavita AG
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This pharmaceutical company develops and commercialises anti-infective drugs for women's health, specifically targeting gynecological infections for patients globally.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Coologics
This clinical-stage medical device company develops a drug-free intravaginal cooling device to treat vaginal infections for female patients.
Matrubials
This biotechnology company develops milk-derived antibacterial therapeutics to treat infectious diseases like bacterial vaginosis for women.
Iterum Therapeutics
This pharmaceutical company develops and commercialises oral and intravenous antibiotics for patients with multi-drug resistant infections, including urinary tract infections.
Gesynta
This pharmaceutical company develops non-hormonal oral treatments targeting chronic inflammation and pain for patients with endometriosis and other inflammatory conditions.
Omnix Medical
This biopharmaceutical company develops novel antibiotic agents for patients suffering from life-threatening, drug-resistant bacterial infections.
Gesynta Pharma
This company develops anti-inflammatory and pain-relieving oral pharmaceuticals targeting the mPGES-1 enzyme for patients with endometriosis and chronic inflammatory conditions.
VISUfarma
This company develops and commercialises ophthalmic pharmaceuticals and medical devices for patients with eye conditions like glaucoma and dry eye disease.
Speciality European Pharma
This company develops and distributes pharmaceutical products and medical devices for urological and gynaecological conditions to specialist physicians and hospitals across Europe.
